Clinton Malissia
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Melius Research initiates Meritage Homes coverage with Sell rating. Melius Research began tracking Meritage Homes with a Sell rating and a $59 price target. This new negative view adds to recent pressure on the stock, which is currently trading near its 52-week low. The move follows a broader trend of weakness in the homebuilder sector, as seen in recent declines for peers like Lennar.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Progyny (PGNY) shares rise over 6% amid record sales pace. Shares of Progyny jumped about 6% after the company reported a selling season that is pacing toward a record level. Analysts noted the move while also comparing the stock’s valuation to peers such as CRL. The price action comes as the stock trades with an RSI near 61 and holds above a support level around $25.40. The news adds to recent discussion about potential upside, though the stock remains below its 52‑week high.
Transaction History
| DDD | ▲ Buy | Grant | 45,731 | $0 | 5/14/2026 | View on chart |
| MTH | ▲ Buy | Grant | 7,760 | $0 | 3/23/2026 | View on chart |
| MTH | ▼ Sell | Open Market | 4,405 | $334K | 2/23/2026 | View on chart |
| MTH | ▼ Sell | Open Market | 548 | $42K | 2/23/2026 | View on chart |
| MTH | ▼ Sell | Open Market | 232 | $18K | 2/23/2026 | View on chart |
| MTH | ▲ Buy | Grant | 8,001 | $0 | 2/20/2026 | View on chart |
| MTH | ▼ Sell | Open Market | 5,361 | $383K | 8/12/2025 | View on chart |
| MTH | ▼ Sell | Open Market | 1,157 | $83K | 8/12/2025 | View on chart |
| MTH | ▲ Buy | Grant | 8,623 | $0 | 8/10/2025 | View on chart |
| DDD | ▲ Buy | Grant | 29,069 | $0 | 6/11/2025 | View on chart |
| MTH | ▲ Buy | Grant | 6,415 | $0 | 2/20/2025 | View on chart |
| DDD | ▲ Buy | Grant | 63,084 | $0 | 8/30/2024 | View on chart |
| MTH | ▲ Buy | Grant | 2,996 | $0 | 2/22/2024 | View on chart |
| DDD | ▼ Sell | Open Market | 8,685 | $74K | 5/18/2023 | View on chart |
| DDD | ▲ Buy | Grant | 18,094 | $0 | 5/16/2023 | View on chart |
| MTH | ▲ Buy | Grant | 3,819 | $0 | 2/20/2023 | View on chart |
| MTH | ▲ Buy | Grant | 3,322 | $0 | 8/10/2022 | View on chart |
| DDD | ▼ Sell | Open Market | 6,006 | $62K | 5/25/2022 | View on chart |
| DDD | ▲ Buy | Grant | 15,015 | $0 | 5/24/2022 | View on chart |
| DDD | ▼ Sell | Open Market | 4,375 | $70K | 3/18/2022 | View on chart |
| PGNY | ▲ Buy | Grant | 2,210 | $0 | 10/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
3D Systems stock shows relative outperformance vs peers
A recent Yahoo analysis notes that DDD has been gaining more than other industrial products companies this year. The comparison highlights the company's relative strength in its sector. This context may be useful for investors watching peer performance trends.
3D Systems stock shows relative outperformance vs peers. A recent Yahoo analysis notes that DDD has been gaining more than other industrial products companies this year. The comparison highlights the company's relative strength in its sector. This context may be useful for investors watching peer performance trends.